Home LiteratureArticle Details
PMID: 23222814 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells.

Carcinogenesis ·Vol. 34 ·No. 3 ·2013-03-00 ·Pages 703-12

Dairkee SH, Luciani-Torres MG, Moore DH, Goodson WH

Abstract

Widespread distribution of bisphenol-A (BPA) complicates epidemiological studies of possible carcinogenic effects on the breast because there are few unexposed controls. To address this challenge, we previously developed non-cancerous human high-risk donor breast epithelial cell (HRBEC) cultures, wherein BPA exposure could be controlled experimentally. BPA consistently induced activation of the mammalian target of rapamycin (mTOR) pathway--accompanied by dose-dependent evasion of apoptosis and increased proliferation--in HRBECs from multiple donors. Here, we demonstrate key molecular changes underlying BPA-induced cellular reprogramming. In 3/3 BPA-exposed HRBEC cell lines, and in T47D breast cancer cells, proapoptotic negative regulators of the cell cycle (p53, p21(WAF1) and BAX) were markedly reduced, with concomitant increases in proliferation-initiating gene products (proliferating cell nuclear antigen, cyclins, CDKs and phosphorylated pRb). However, simultaneous exposure to BPA and the polyphenol, curcumin, partially or fully reduced the spectrum of effects associated with BPA alone, including mTOR pathway proteins (AKT1, RPS6, pRPS6 and 4EBP1). BPA exposure induced an increase in the ERα (Estrogen Receptor): ERβ ratio--an effect also reversed by curcumin (analysis of variance, P < 0.02 for all test proteins). At the functional level, concurrent curcumin exposure reduced BPA-induced apoptosis evasion and rapid growth kinetics in all cell lines to varying degrees. Moreover, BPA extended the proliferation potential of 6/6 primary finite-life HRBEC cultures--another effect reduced by curcumin. Even after removal of BPA, 1/6 samples maintained continuous growth--a hallmark of cancer. We show that BPA exposure induces aberrant expression of multiple checkpoints that regulate cell survival, proliferation and apoptosis and that such changes can be effectively ameliorated.

MeSH Terms
Apoptosis Apoptosis Regulatory Proteins/metabolism Benzhydryl Compounds/pharmacology Breast Neoplasms Cell Cycle/drug effects Cell Cycle Proteins/metabolism Cell Proliferation/drug effects Cell Survival/drug effects Curcumin/pharmacology Down-Regulation/drug effects Epithelial Cells/drug effects,metabolism,physiology Estrogen Receptor alpha/agonists,metabolism Estrogens, Non-Steroidal/pharmacology Female Humans Hydroxytestosterones/pharmacology Kinetics Mammary Glands, Human/pathology Phenols/pharmacology Primary Cell Culture Signal Transduction TOR Serine-Threonine Kinases/metabolism Tumor Suppressor Protein p53/genetics,metabolism
Chemicals
Apoptosis Regulatory Proteins Benzhydryl Compounds Cell Cycle Proteins ESR1 protein, human Estrogen Receptor alpha Estrogens, Non-Steroidal Hydroxytestosterones Phenols TP53 protein, human Tumor Suppressor Protein p53 4,17 beta-dihydroxy-4-androstene-3-one TOR Serine-Threonine Kinases Curcumin bisphenol A
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Dairkee Shanaz H
California Pacific Medical Center Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA. [email protected]
Luciani-Torres M Gloria
Moore Dan H
Goodson William H
References (41)
41 references, click to expand
  1. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
    Cancer Res. 2008 Apr 1;68(7):2076-80 PMID: 18381411
  2. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Cancer Res. 2007 Aug 15;67(16):7746-55 PMID: 17699779
  3. Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells.
    Carcinogenesis. 2012 Apr;33(4):868-75 PMID: 22298641
  4. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004.
    Environ Health Perspect. 2008 Jan;116(1):39-44 PMID: 18197297
  5. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88 PMID: 9747868
  6. Nuclear matrix protein mitotin messenger RNA is expressed at constant levels during the cell cycle.
    Biochem Biophys Res Commun. 1991 May 31;177(1):395-400 PMID: 1710453
  7. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Endocrinology. 1999 Dec;140(12):5566-78 PMID: 10579320
  8. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.
    Oncogene. 2007 Sep 20;26(43):6269-79 PMID: 17471242
  9. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving.
    Endocrinology. 1993 Jun;132(6):2279-86 PMID: 8504731
  10. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland.
    Endocrinology. 2007 Jan;148(1):116-27 PMID: 17023525
  11. p53 as a marker of prognosis in African-American women with breast cancer.
    Ann Surg Oncol. 2010 May;17(5):1398-405 PMID: 20049641
  12. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6.
    Science. 2000 Jun 16;288(5473):2045-7 PMID: 10856218
  13. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
    Oncogene. 2009 Aug 20;28(33):2925-39 PMID: 19561645
  14. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    J Clin Oncol. 2003 Dec 1;21(23):4306-13 PMID: 14645419
  15. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure.
    Toxicol Sci. 2011 Sep;123(1):48-57 PMID: 21705716
  16. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    JAMA. 2002 Jul 17;288(3):321-33 PMID: 12117397
  17. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Breast Cancer Res Treat. 1986;7 Suppl:S83-90 PMID: 3742066
  18. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
    J Clin Invest. 2010 Jul;120(7):2406-13 PMID: 20530877
  19. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
    Cancer Res. 2009 Feb 1;69(3):1000-8 PMID: 19176385
  20. Li-Fraumeni syndrome--a molecular and clinical review.
    Br J Cancer. 1997;76(1):1-14 PMID: 9218725
  21. The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells.
    Prostate. 2012 May 1;72(6):612-25 PMID: 21796654
  22. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure.
    Reprod Toxicol. 2007 Apr-May;23(3):383-90 PMID: 17123778
  23. Exemestane for breast-cancer prevention in postmenopausal women.
    N Engl J Med. 2011 Jun 23;364(25):2381-91 PMID: 21639806
  24. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
    Cell. 1993 Aug 27;74(4):609-19 PMID: 8358790
  25. Interaction of estrogen receptor alpha with proliferating cell nuclear antigen.
    Nucleic Acids Res. 2007;35(15):5028-38 PMID: 17636311
  26. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.
    Am J Surg Pathol. 2003 Dec;27(12):1502-12 PMID: 14657709
  27. mTOR and cancer: insights into a complex relationship.
    Nat Rev Cancer. 2006 Sep;6(9):729-34 PMID: 16915295
  28. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells.
    J Cell Biochem. 2003 May 1;89(1):1-5 PMID: 12682902
  29. Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer.
    Horm Mol Biol Clin Investig. 2011 Mar 1;5(2):45-52 PMID: 21687816
  30. Bisphenol A alters the development of the rhesus monkey mammary gland.
    Proc Natl Acad Sci U S A. 2012 May 22;109(21):8190-5 PMID: 22566636
  31. 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.
    Cancer Res. 2007 Aug 15;67(16):7551-5 PMID: 17699757
  32. Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats.
    J Steroid Biochem Mol Biol. 1997 Jan;60(1-2):153-60 PMID: 9182870
  33. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
    N Engl J Med. 2012 Feb 9;366(6):520-9 PMID: 22149876
  34. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids.
    Environ Health Perspect. 1998 Dec;106(12):807-12 PMID: 9831541
  35. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin.
    Breast Cancer Res Treat. 1999 Apr;54(3):269-78 PMID: 10445426
  36. Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways.
    BMC Cancer. 2010 Oct 21;10:573 PMID: 20964848
  37. Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.
    Am J Pathol. 1991 Jun;138(6):1371-7 PMID: 2053594
  38. PCNA, the maestro of the replication fork.
    Cell. 2007 May 18;129(4):665-79 PMID: 17512402
  39. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
    Cancer Res. 2006 Oct 1;66(19):9461-6 PMID: 17018601
  40. Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.
    Carcinogenesis. 2011 Nov;32(11):1724-33 PMID: 21890461
  41. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
    Cancer Res. 2001 Feb 15;61(4):1741-6 PMID: 11245491
Article Info
Journal
Carcinogenesis
Abbr.
Carcinogenesis
ISSN
1460-2180
Published
2013-03-00
Epub
2012-00-07
Pages
703-12
Language
English
Region
England
NLM ID
8008055
PMCID
PMC3581603
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]